Cooper A B, Doig G S, Sibbald W J
Program in Critical Care, University of Western Ontario, London, Canada.
Crit Care Clin. 1996 Oct;12(4):777-94. doi: 10.1016/s0749-0704(05)70279-7.
Evidence-based approaches to assessing the clinical literature are used increasingly in issues relating to critical care medicine. As we discussed previously, this approach attempts to provide a logical and convenient framework from which the quality and relevance of clinical studies may be assessed in an unbiased manner. An evidence-based approach also allows the reader to differentiate between solid evidence and evidence that is based on a presumed mechanism, standard practice, or conventional wisdom. Evidence-based medicine that deemphasizes intuition, unsystemic clinical experience, and pathophysiologic rationale is sufficient grounds for clinical decision making and stresses the examination of evidence from clinical research. Importantly, it is the objective nature by which the evidence-based medicine paradigm approaches the questions of "What are we doing" and "How can we do better," that causes health care providers and funding agencies to increasingly adopt this paradigm as a primary principle. The role of evidence-based medicine, therefore, is not to discount expert opinion but, wherever possible, to require that recommendations be based on the results of rigorous and controlled scientific study. We introduced this article by highlighting the growing imbalance between resources and patient needs in the critical care environment. At the level of diagnostic technology and therapeutic care plans, critical care professionals increasingly are asked to identify strategies to improve efficiencies-approaches with rigorous costs that at the same time promote better patient care. Formalized technology assessment is one of the mechanisms to accomplish this. Using critical appraisal within the context of evidence-based medicine is one of the mechanisms by which data can be synthesized to describe technology assessment. In this example, we used controversies surrounding use of pulmonary artery catheterization in critically ill patients to highlight some of the principles of evidence-based medicine at the bedside. We introduced how a particular case example can be used to ask the question, "What is the evidence that a particular diagnostic technology or therapeutic modality improves outcome?" In the case of PACs, no one would argue that a diagnostic technology a priori leads to improved outcome; rather, we have to presume that given good data, the care provider will apply the most appropriate management strategy. In this case example, however, we demonstrate how the critical appraisal process should identify a search strategy to find the most appropriate evidence to support the questioning process. From this, the evidence can be critically appraised and tabulated. In the case of the PAC, Table 13 demonstrates that there are few data to identify a grade A recommendation that the PAC should be used as part of the care process in critically ill patients. Finding that there is little evidence to support the use of pulmonary artery catheterization in the clinical literature does not mean that this diagnostic technology is neither efficacious nor effective. It might well be that information provided by PACs is important in the care process. However, what this exercise has taught us is that there is little objective evidence to support this conclusion. The challenge to critical care practitioners is not only to apply the evidence-based processes more frequently to our environment but also to use the information to separate out clearly what is fact versus opinion. Where there is little evidence to support a particular clinical practice, as we have demonstrated with the PAC review earlier, the challenge to the clinician should be the design and conduct of clinical trials clarifying debate between opinion and evidence.
循证方法在评估临床文献时越来越多地应用于危重症医学相关问题。如我们之前所讨论的,这种方法试图提供一个逻辑且便捷的框架,以便能以无偏倚的方式评估临床研究的质量和相关性。循证方法还能让读者区分确凿证据与基于假定机制、标准做法或传统观念的证据。循证医学淡化直觉、非系统性临床经验和病理生理原理,足以作为临床决策的依据,并强调对临床研究证据的审查。重要的是,循证医学范式以客观的方式处理“我们在做什么”以及“我们如何能做得更好”这些问题,这使得医疗服务提供者和资助机构越来越多地将这种范式作为首要原则。因此,循证医学的作用并非摒弃专家意见,而是尽可能要求建议基于严谨且受控的科学研究结果。我们在文章开篇强调了危重症环境中资源与患者需求之间日益增长的不平衡。在诊断技术和治疗护理计划层面,危重症专业人员越来越多地被要求确定提高效率的策略——采用严格控制成本的方法,同时促进更好的患者护理。正式的技术评估是实现这一目标的机制之一。在循证医学背景下进行批判性评价是综合数据以描述技术评估的机制之一。在这个例子中,我们利用围绕危重症患者使用肺动脉导管插入术的争议,来突出床边循证医学的一些原则。我们介绍了如何利用一个特定的案例来提出问题:“有什么证据表明某种特定的诊断技术或治疗方式能改善预后?”就肺动脉导管插入术而言,没有人会认为一种诊断技术先验地就能改善预后;相反,我们必须假定在有良好数据的情况下,医疗服务提供者会应用最合适的管理策略。然而,在这个案例中,我们展示了批判性评价过程应如何确定一种检索策略,以找到最合适的证据来支持提问过程。据此,可对证据进行批判性评价并列表呈现。以肺动脉导管插入术为例,表13表明几乎没有数据能支持A级推荐,即肺动脉导管插入术应作为危重症患者护理过程的一部分使用。在临床文献中发现几乎没有证据支持使用肺动脉导管插入术,并不意味着这种诊断技术既无疗效也无效果。很可能肺动脉导管插入术提供的信息在护理过程中很重要。然而,这个实践让我们明白,几乎没有客观证据支持这一结论。危重症从业者面临的挑战不仅是在我们的环境中更频繁地应用循证过程,还在于利用这些信息清楚地区分事实与观点。当几乎没有证据支持某种特定临床实践时,正如我们之前对肺动脉导管插入术综述所表明的,临床医生面临的挑战应该是设计和开展临床试验,以澄清观点与证据之间的争论。